EP Patent

EP3663294A1 — Substituted heterocycle fused gamma-carbolines synthesis

Assigned to Intra Cellular Therapies Inc · Expires 2020-06-10 · 6y expired

What this patent protects

The present invention provides a compound of the formula (I)as well as a method of making a compound of the formula (II) comprising the step of N-alkylating the compound of formula (I)

USPTO Abstract

The present invention provides a compound of the formula (I)as well as a method of making a compound of the formula (II) comprising the step of N-alkylating the compound of formula (I)

Drugs covered by this patent

Patent Metadata

Patent number
EP3663294A1
Jurisdiction
EP
Classification
—
Expires
2020-06-10
Drug substance claim
No
Drug product claim
No
Assignee
Intra Cellular Therapies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.